Skip to content

The Rapid Adoption of Intelligent Manufacturing and Pharma 4.0 during COVID-19

  • April 26, 2021

Among the many things that the COVID-19 pandemic brought to light, life science organizations were faced with the immediate need to improve the reliability, safety, scalability, and speed to market of their offerings.

This much is clear: Gone are the days of using inefficient, cumbersome paper procedures and disconnected systems. Today’s complex manufacturing organizations are under great pressure to simultaneously speed up their processes while ensuring top quality.

In order to meet today’s demands, the adoption of intelligent technology and remote collaboration platforms is crucial⁠—empowering organizations to efficiently connect their people, processes, and environments. Through leveraging intelligent technology and Pharma 4.0 connected systems, organizations are able to:

  • Connect, monitor, and support their various teams in real-time
  • Significantly improve batch yield
  • Effectively manage resources
  • Utilize guided workflow assistance
  • Gather, query, and store the critical data needed to improve efficiency, reliability, compliance, and speed

Learn more in this exclusive Apprentice e-book:

RELATED NEWS

Executive Summits: Choosing 1-2-1 Quality Over Trade Show Floor Noise

In an era where digital noise is at an all-time high, the B2B landscape is witnessing a significant shift in how...

by Clarissa Wong

Cross-Functional Leadership in Manufacturing: How Enrique Porras of RPM is Maximizing Performance [Speaker Spotlight]

As operational demands intensify and the pressure to maximize performance grows, manufacturers must optimize every...

by Rihana Alladina